Results 161 to 170 of about 74,509 (297)

Health Care Professionals' Perceptions of the Role of Pharmacogenomic Data [PDF]

, 2002
Woodie Zachary, Edward P. Armstrong
openalex   +1 more source

Novel Humanized Mouse Model for Steroid‐Resistant Asthma

Allergy, EarlyView.
Shiho Yamada, Shuichiro Maruoka, Shota Toyoshima, Yusuke Kurosawa, Ryosuke Ozoe, Yutaka Kozu, Kenji Mizumura, Yoshimichi Okayama, Ryoji Ito, Yasuhiro Gon   +9 more
wiley   +1 more source

Making the Old New Again Through the Process of Recombinant Innovation

Journal of Product Innovation Management, EarlyView.
ABSTRACT Academic Summary Recombinant innovation—the process through which atypical and unexpected combinations of knowledge generate novel outcomes—is a critical driver of organizational distinctiveness and market transformation. While prior research has focused on firm‐ and industry‐level mechanisms, less attention has been given to multilevel ...
Vittoria Magrelli, Josip Kotlar, Alfredo De Massis, Federico Frattini, Antonio Messeni Petruzzelli   +4 more
wiley   +1 more source

The challenges of delivering pharmacogenomics into clinical pediatrics [PDF]

, 2002
J. Steven Leeder, Gregory L. Kearns
openalex   +1 more source

Clinical significance and immune microenvironment association of cuproptosis‐related genes in pan‐cancer

Experimental Physiology, EarlyView.
Abstract Recent studies highlight the important roles of cuproptosis in cancer cells. However, the roles of the cuproptosis‐related genes (CRGs) in different cancers are still not fully understood. Comprehensive analysis was performed using open‐source bioinformatic platforms to disclose the expression profiles, prognostic significance, genomic and ...
Xinyu Ge, Kaijing Wang, Tian Zhao, Jinyi Wang, Jie Liu, Zhengliang Sun, Zhengjun Chai, Wen Zhang, Chengbao Li, Yan Xu, Guohan Chen   +10 more
wiley   +1 more source

The association between white blood cell count and relative risk of non-small cell lung cancer

Discover Oncology
Background High abundance of eosinophils has been proved to associated with favorable disease progression in non-small cell lung cancer (NSCLC) in the previous observational studies, but the causal relationship remains unclear. It is also unclear whether
Xiao Yang, Wenyi Liu, Jiaqi Wang, Weifeng Xia, Lanxiang Wu   +4 more
doaj   +1 more source

Pharmacogenomics and Therapeutic Target Validation in Cerebral Vasospasm

, 2000
Toshio Tanaka, Yuhei Nishimura, Hiroshi Tsunoda, Michiko Naka   +3 more
openalex   +1 more source

Pharmacogenomics: The implementation phase [PDF]

, 2002
Wolfgang Sadée
openalex   +1 more source

Pharmacogenomics: Revolution in a Bottle? [PDF]

, 2002
Faith Lagay
openalex   +1 more source

Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing

International Journal of Cancer, Volume 157, Issue 9, Page 1898-1911, 1 November 2025.
What's new? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters, Didier Meulendijks, Zerina Kadric, Sara Ibrovic, Geert‐Jan Creemers, Vanja Milosevic, Matthijs van de Poll, Lieke H. J. Simkens, Birgit A. L. M. Deiman, Hans Gelderblom, Henk‐Jan Guchelaar, Anna M. J. Thijs, Maarten J. Deenen   +12 more
wiley   +1 more source